Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells
- 1 January 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (3) , 351-358
- https://doi.org/10.1016/0006-2952(94)00492-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tamoxifen inhibits lipid peroxidation in cardiac microsomes: Comparison with liver microsomes and potential relevance to the cardiovascular benefits associated with cancer prevention and treatment by tamoxifenBiochemical Pharmacology, 1993
- Breast CancerNew England Journal of Medicine, 1992
- Breast CancerNew England Journal of Medicine, 1992
- Breast CancerNew England Journal of Medicine, 1992
- Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatmentThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agarBreast Cancer Research and Treatment, 1991
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- A simple, rapid, and sensitive DNA assay procedureAnalytical Biochemistry, 1980